8618058805204marketing@bio-engine.com.cn
enLanguage

Home / News / Content

BioEngine Sci-Tech And Rongsheng Biotech Signed A Strategic Cooperation Agreement

May 30, 2020

Leave a message

On March 29, 2020, Tan Wensong, chairman of Shanghai BioEngine Sci-Tech Co., Ltd., and Zhu Shaorong, chairman of Shanghai Rongsheng Biotech Co., Ltd, signed a strategic cooperation agreement at Shanghai Rongsheng Biotech Co., Ltd. Both parties will cooperate to jointly promote the application of animal cell mass culture technology in the development and efficient industrial production of human virus vaccine products.

 

1585544073985040.jpg

news-1519-1014

Send Inquiry

Provide high quality culture media for research institutions, biopharmaceutical companies and clinical trial institutions, etc.

I agree to receive other communications from BioEngine which may contain technical or marketing information from this organization. You can unsubscribe from these communications at any time.
By submitting this form, you are agreeing to the terms and conditions of our Privacy Policy

Professional Cell Culture Solutions for Biopharmaceutical Development

Our expert scientific team delivers end-to-end cell culture services to support your biopharmaceutical production needs. We provide comprehensive solutions including:
- Process development & optimization
- Customized medium formulation design
- Scalable medium processing & GMP manufacturing

For technical inquiries or service requests, please submit your message through our [Quick Message] portal. Our specialists will respond within 24 business hours.

Quick Message